Profit

Alkem Labs Mops Up Rs 395 Crore From Anchor Investors

 Share
EMAIL
PRINT
COMMENTS
Alkem Labs Mops Up Rs 395 Crore From Anchor Investors
New Delhi: Alkem Laboratories has raised Rs 395 crore from anchor investors, including Abu Dhabi Investment Fund, by allotting shares at Rs 1,050 per scrip.

For the initial public offerings (IPO), the company has fixed a price band of Rs 1,020-1,050 apiece. Through the initial share sale, which opens on Tuesday and closes on Thursday, Alkem is aiming to raise around Rs 1,350 crore.

More than 3.7 million shares were allotted to anchor investors at a price of Rs 1,050 apiece. This would be worth Rs 395.47 crore, according to a regulatory filing made by the company.

The anchor investors include Abu Dhabi Investment Authority-Behave, DSP Blackrock Mutual Fund, Morgan Stanley Mauritius Company Ltd, Apax Global, SBI Pharma Fund and Kuwait Investment Authority.

Axis Mutual Fund, IDFC Classic Equity Fund, HDFC Small and Mid Cap Fund, Franklin Templeton Mutual Fund, HDFC Standard Life Insurance Company Ltd and Tata Balanced Fund are among other anchor investors.

The global coordinators and book running lead managers (GCBRLMs) to the issue are Nomura Financial Advisory and Securities (India), Axis Capital Ltd, JP Morgan India Pvt Ltd and Edelweiss Financial Services Ltd.

Alkem plans to expand its footprint internationally. It had a portfolio of 705 brands in the domestic market as on September 30.


Get Breaking news, live coverage, and Latest News from India and around the world on NDTV.com. Catch all the Live TV action on NDTV 24x7 and NDTV India. Like us on Facebook or follow us on Twitter and Instagram for latest news and live news updates.

NDTV Beeps - your daily newsletter

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Top